News/Details

TFDA Approval for Organ Bank – ECM Biomedical Becomes Taiwan’s Only ADM & DBM Developer and Asia’s Sole Company with Amniotic, Bone, and ADM Technologies

2025-08-31

Passed TFDA review and obtained establishment approval for the Human Organ Preservation Bank – Cortical Bone, Bone Powder, and Skin.

Disclaimer

• ECM Biomedical Co., Ltd. (hereinafter referred to as “ECM Biomedical”) provides the information on this website solely for general educational and informational purposes, and it cannot replace the diagnosis, treatment, or consultation advice of medical professionals. ECM Biomedical reserves the right to modify the content of this website in any way, at any time, and for any purpose without prior notice. Any changes will take effect immediately upon publication on this site.

• For the convenience of visitors, ECM Biomedical may provide links to other websites. Since the linked websites are not under the management or control of ECM Biomedical, the company does not provide any guarantee or assume any responsibility for the content of linked websites or any damages resulting from such links.

• Please pay attention to this disclaimer when browsing this website. By continuing to use this site, you agree to be bound by the revised disclaimer. ECM Biomedical does not provide any guarantee or assume any responsibility for any potential consequences or impacts arising from subsequent modifications or changes.

© 2021 Landify UI Kit. All rights reserved